Health Care Weekly Preview from ML Strategies – November 2018 #2

Mintz - Health Care Viewpoints

This week, Congress returns to Washington for its lame duck session with uncertain expectations for what gets done between now and the next funding deadline of December 7, 2018. There are a number of legislative items that passed one chamber and not the other, and watch to see which bills make it across the finish line. One example, and the most likely to get done, is the recently expired Pandemic and All - Hazards Preparedness Reauthorization Act (PAHPA), which was passed by the House but awaits Senate consideration.

The political reality that Democrats will control the House in 2019 will begin to take shape and play a role in what moves during the lame duck. In other words, Democrats can be strategic in what they allow to move during the lame duck. While the CREATES Act has garnered bipartisan support, Democrats may be less inclined to accept any compromise offers so House Democrats have more control in what language is considered in a new Congress.

Please see full Preview below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Mintz - Health Care Viewpoints | Attorney Advertising

Written by:

Mintz - Health Care Viewpoints

Mintz - Health Care Viewpoints on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.